Cargando…

Fertility preservation in breast cancer with oral progestin: is it an option? A pilot study

OBJECTIVE: To compare the effectiveness of oral progestins and injectable gonadotropin-releasing hormone antagonist medication in cancer fertility preservation in patients with breast cancer. METHODS: A cross-sectional study with 40 breast cancer patients submitted to cancer fertility preservation,...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Oliveira, Renato, Maya, Bárbara Gomes, Nogueira, Mariana Bittencourt Silva, Conceição, Gabriel Seixas, Bianco, Bianca, Barbosa, Caio Parente
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto Israelita de Ensino e Pesquisa Albert Einstein 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354590/ https://www.ncbi.nlm.nih.gov/pubmed/34431852 http://dx.doi.org/10.31744/einstein_journal/2021AO5859

Ejemplares similares

Preimplantation genetic diagnosis associated to Duchenne muscular dystrophy
por: Bianco, Bianca, et al.
Publicado: (2017)

Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation
por: Huang, Haipeng, et al.
Publicado: (2022)

Progestin-primed ovarian stimulation for fertility preservation in women with cancer: A comparative study
por: Filippi, Francesca, et al.
Publicado: (2023)

Risk of ovarian hyperstimulation syndrome in women with malignancies undergoing treatment with long-acting gonadotropin-releasing hormone agonist after controlled ovarian hyperstimulation for fertility preservation: a systematic review
por: Ingold, Caroline, et al.
Publicado: (2023)

Disorders of Sex Development—Novel Regulators, Impacts on Fertility, and Options for Fertility Preservation
por: Gomes, Nathalia Lisboa, et al.
Publicado: (2020)

Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer
por: Falcone, Francesca, et al.
Publicado: (2017)

Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols
por: Mathieu d’Argent, Emmanuelle, et al.
Publicado: (2020)

Prognostic factors of oncologic outcomes after fertility-preservative management with progestin in early-stage of endometrial cancer
por: Roh, Hyun Jin, et al.
Publicado: (2021)

Fertility preservation options for transgender individuals
por: Sterling, Joshua, et al.
Publicado: (2020)

Cancer fertility preservation: a report from a Brazilian social program
por: Berton, Caroline Z, et al.
Publicado: (2020)

Low dose of rFSH [100 IU] in controlled ovarian hyperstimulation response: a pilot study
por: Barbosa, Caio Parente, et al.
Publicado: (2014)

Fertility-preserving treatment in complex atypical hyperplasia and early endometrial cancer in young women with oral progestin: Is it effective?
por: Baek, Ji Sun, et al.
Publicado: (2016)

Fertility Preservation and Potential Future Treatment Options
por: Sadeghi, Mohammad Reza
Publicado: (2014)

Fertility Preservation Options After Gonadotoxic Chemotherapy
por: Hyman, Jordana Hadassah, et al.
Publicado: (2013)

Female Fertility Preservation, Clinical and Experimental Options
por: Rajabi, Zahra, et al.
Publicado: (2018)

Fertility preservation options for transgender and nonbinary individuals
por: Reckhow, Jensen, et al.
Publicado: (2023)

Recent advances: fertility preservation and fertility restoration options for males and females
por: Doungkamchan, Chatchanan, et al.
Publicado: (2021)

Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for women
por: Kim, So-Youn, et al.
Publicado: (2016)

Fertility Preservation in Cancer Patients: In Vivo and In Vitro Options
por: Fathi, Rouhollah, et al.
Publicado: (2017)

Prevalence of inter-hemispheric asymetry in children and adolescents with interdisciplinary diagnosis of non-verbal learning disorder
por: Wajnsztejn, Alessandra Bernardes Caturani, et al.
Publicado: (2016)

Fertility-Preserving Treatment Options in Patients with Malignant Hematological Diseases
por: Küçük, Mert, et al.
Publicado: (2012)

Fertility preservation in endometrial cancer patients: options, challenges and perspectives
por: Terzic, Milan, et al.
Publicado: (2020)

Rhabdomyosarcoma of the cervix in teenagers – Is fertility preservation a feasible option?
por: Buruiana, F.E., et al.
Publicado: (2020)

Dual progestin therapy for fertility-sparing treatment of grade 2 endometrial adenocarcinoma
por: Newtson, A.M., et al.
Publicado: (2017)

Progesterone level on the day of hCG administration in relation to the pregnancy rates of patients undergoing assisted reproduction techniques
por: de Oliveira, Renato, et al.
Publicado: (2017)

Oral health-related quality of life in patients aged 8 to 19 years with cleft lip and palate: a systematic review and meta-analysis
por: de Oliveira Júnior, Augusto Garcia, et al.
Publicado: (2023)

Survey of Fertility Preservation Options Available to Patients With Cancer Around the Globe
por: Rashedi, Alexandra S., et al.
Publicado: (2020)

Incidence of Y-chromosome microdeletions in children whose fathers underwent vasectomy reversal or in vitro fertilization with epididymal sperm aspiration: a case-control study
por: Ghirelli-Filho, Milton, et al.
Publicado: (2016)

Impact of blood levels of progesterone on the day of ovulation onset on clinical, laboratory and reproductive parameters of young patients undergoing assisted reproduction: a cross-sectional study
por: Fernandez, Renata Garcia Olmos, et al.
Publicado: (2022)

Progestin and Nuclear Progestin Receptor Are Essential for Upregulation of Metalloproteinase in Zebrafish Preovulatory Follicles
por: Liu, Dong Teng, et al.
Publicado: (2018)

Association of the protein tyrosine phosphatase non-receptor 22 polymorphism (PTPN22) with endometriosis: a meta-analysis
por: Pabalan, Noel, et al.
Publicado: (2017)

ESHRE guideline: female fertility preservation
por: Anderson, Richard A, et al.
Publicado: (2020)

Endometrial cancer: a genetic point of view
por: Bianco, Bianca, et al.
Publicado: (2020)

Body Mass Index Showed No Impact on the Outcome of In Vitro Fertilization in Progestin-Primed Ovarian Stimulation Protocol
por: Yang, Zhe, et al.
Publicado: (2021)

Progestins and mammary cancer induction.
por: Coezy, E., et al.
Publicado: (1973)

Metformin: a novel promising option for fertility preservation during cyclophosphamide-based chemotherapy
por: Huang, Chu-Chun, et al.
Publicado: (2021)

Fertility Preservation and Restoration Options for Pre-Pubertal Male Cancer Patients: Current Approaches
por: Eugeni, Elena, et al.
Publicado: (2022)

The Progestin Revolution: progestins are arising as the dominant players in the tight interlink between contraceptives and bleeding control
por: Shoupe, Donna
Publicado: (2021)

Fertility Preservation
por: Taitson, Paulo Franco, et al.
Publicado: (2016)

The progins progesterone receptor gene polymorphism is not related to endometriosis‐associated infertility or to idiopathic infertility
por: Gimenes, Cristiane, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_h5onutern0tuce1qih5susga36